Antares Pharma Inc

NASDAQ:ATRS  
3.29
-0.06 (-1.79%)
Positive Earnings Pre-Announcement, Mergers / Acquisitions

Assertio Holdings Announces Acquisition Of Otrexup

Published: 12/15/2021 22:56 GMT
Antares Pharma Inc (ATRS) - Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination From Antares Pharma, Inc.assertio Holdings Inc - Raises Full Year Net Product Sales and Non-GAAP Adjusted EBITDA Guidance.
Assertio Holdings Inc - Acquired Otrexup From Antares in a Partially Seller Financed Transaction for a Total Purchase Price of $44.0 Million.
Assertio Holdings Inc - Sees 2021 Full Year Net Product Sales Greater Than $108 Million.
Assertio Holdings Inc - Will Pay Antares $18.0 Million Upfront and an Additional $26.0 Million in Deferred Payments.
Assertio Holdings Inc - Acquisition Will Be Accretive to Adjusted EBITDA in 2022.
Revenue is expected to be $47.45 Million
Adjusted EPS is expected to be $0.02

Next Quarter Revenue Guidance is expected to be $45.67 Million
Next Quarter EPS Guidance is expected to be $0.02

More details on our Analysts Page.